Group 1 - The company's organic sales remained flat, with a total sales decline of 1% compared to Q1 2024 [1] - Adjusted EBITDA for Q1 2025 was €357 million, maintaining an adjusted EBITDA margin of 13.7% at constant exchange rates, unchanged from the previous year [1] - Cost reduction and efficiency measures have progressed faster than expected, effectively offsetting the impact of declining sales and inflation pressures [1] Group 2 - The CEO of AkzoNobel stated that the performance exceeded expectations due to pricing strategies and strong cost-cutting initiatives, which helped mitigate the effects of market weakness and ongoing inflation [1] - The company anticipates that adjusted EBITDA for 2025 will exceed €1.55 billion, based on current market volatility and constant exchange rates [3] - AkzoNobel aims to achieve an adjusted EBITDA margin exceeding 16% and a return on investment between 16% and 19% through organic growth and operational excellence [3] Group 3 - The company plans to reduce its net debt/adjusted EBITDA leverage ratio to below 2.5 times by the end of 2025, with a mid-term target of approximately 2 times, while maintaining a strong investment-grade credit rating [3]
降本增效与价格策略双驱动，阿克苏诺贝尔第一季度业绩表现强劲
Jin Tou Wang·2025-04-24 08:55